196 related articles for article (PubMed ID: 33046419)
1. Assessment of empiric body mass index-based thromboprophylactic dosing of enoxaparin after bariatric surgery: evidence for dosage adjustment using anti-factor Xa in high-risk patients.
Karas LA; Nor Hanipah Z; Cetin D; Schauer PR; Brethauer SA; Daigle CR; Aminian A
Surg Obes Relat Dis; 2021 Jan; 17(1):153-160. PubMed ID: 33046419
[TBL] [Abstract][Full Text] [Related]
2. Underdosing of Prophylactic Enoxaparin Is Common in Orthopaedic Trauma and Predicts 90-Day Venous Thromboembolism.
Jones DL; Jones WA; Fleming KI; Higgins TF; Rothberg DL; Zhang Y; Pannucci CJ
J Orthop Trauma; 2019 Nov; 33(11):570-576. PubMed ID: 31634287
[TBL] [Abstract][Full Text] [Related]
3. Extended use of bemiparin as thromboprophylaxis during bariatric surgery: results of anti-factor Xa activity measurements.
Muñoz-Atienza V; Gil-Rendo A; Amo-Salas M; Núñez-Guerrero P; Martín-Fernández J
Surg Obes Relat Dis; 2018 Mar; 14(3):354-360. PubMed ID: 29361459
[TBL] [Abstract][Full Text] [Related]
4. Are We Missing Treatment Standards for Thromboprophylaxis of the Obese and Super-Obese Patient Population? A Prospective Systematic Cohort Study.
Stier C; Koschker AC; Stier R; Sosnierz A; Chiappetta S
Obes Surg; 2020 May; 30(5):1704-1711. PubMed ID: 31974866
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Anti-factor Xa Levels in Female and Male Patients with Obesity After Enoxaparin Application for Thromboprophylaxis.
Wagner J; Wruck H; Lautenbach A; von Kroge P; Wolter S; Mann O; Izbicki J; Duprée A
Obes Surg; 2022 Mar; 32(3):861-867. PubMed ID: 34988894
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Body Mass Index-Based Prophylactic Enoxaparin Dosing in Bariatric Surgery Patients.
Chang CK; Higgins RM; Rein L; Peppard WJ; Herrmann DJ; Kindel T
J Surg Res; 2023 Jul; 287():168-175. PubMed ID: 36933548
[TBL] [Abstract][Full Text] [Related]
7. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.
Steele KE; Canner J; Prokopowicz G; Verde F; Beselman A; Wyse R; Chen J; Streiff M; Magnuson T; Lidor A; Schweitzer M
Surg Obes Relat Dis; 2015; 11(3):672-83. PubMed ID: 25620436
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism in burns patients: Are we underestimating the risk and underdosing our prophylaxis?
Lu P; Harms KA; Paul E; Bortz H; Lo C; Cleland H
J Plast Reconstr Aesthet Surg; 2021 Aug; 74(8):1814-1823. PubMed ID: 33414092
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Anti-Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin Pharmacokinetics.
Pannucci CJ; Fleming KI; Bertolaccini CB; Prazak AM; Huang LC; Pickron TB
JAMA Surg; 2019 Aug; 154(8):697-704. PubMed ID: 31116389
[TBL] [Abstract][Full Text] [Related]
10. Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.
Singer GA; Riggi G; Karcutskie CA; Vaghaiwalla TM; Lieberman HM; Ginzburg E; Namias N; Lineen EB
J Trauma Acute Care Surg; 2016 Dec; 81(6):1101-1108. PubMed ID: 27488490
[TBL] [Abstract][Full Text] [Related]
11. Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity.
Borkgren-Okonek MJ; Hart RW; Pantano JE; Rantis PC; Guske PJ; Kane JM; Gordon N; Sambol NC
Surg Obes Relat Dis; 2008; 4(5):625-31. PubMed ID: 18261965
[TBL] [Abstract][Full Text] [Related]
12. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of weight-based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients: A systematic review and meta-analysis.
Ebeid A; Cole E; Stallwood-Hall C
J Trauma Acute Care Surg; 2022 Aug; 93(2):e71-e79. PubMed ID: 35583986
[TBL] [Abstract][Full Text] [Related]
14. Enoxaparin dosing after cesarean delivery in morbidly obese women.
Overcash RT; Somers AT; LaCoursiere DY
Obstet Gynecol; 2015 Jun; 125(6):1371-1376. PubMed ID: 26000508
[TBL] [Abstract][Full Text] [Related]
15. Standard Fixed Enoxaparin Dosing for Venous Thromboembolism Prophylaxis Leads to Low Peak Anti-Factor Xa Levels in Both Head and Neck and Breast Free Flap Patients.
Ambani SW; Bengur FB; Varelas LJ; Nguyen VT; Cruz C; Acarturk TO; Manders EK; Kubik MW; Sridharan S; Gimbel ML; Solari MG
J Reconstr Microsurg; 2022 Nov; 38(9):749-756. PubMed ID: 35714620
[TBL] [Abstract][Full Text] [Related]
16. Weight-Based Compared With Fixed-Dose Enoxaparin Prophylaxis After Cesarean Delivery: A Randomized Controlled Trial.
Bruno AM; Allshouse AA; Campbell HM; Branch DW; Lim MY; Silver RM; Metz TD
Obstet Gynecol; 2022 Oct; 140(4):575-583. PubMed ID: 36075079
[TBL] [Abstract][Full Text] [Related]
17. Enoxaparin 40 mg per Day Is Inadequate for Venous Thromboembolism Prophylaxis After Thoracic Surgical Procedure.
Pannucci CJ; Fleming KI; Holoyda K; Moulton L; Prazak AM; Varghese TK
Ann Thorac Surg; 2018 Aug; 106(2):404-411. PubMed ID: 29626461
[TBL] [Abstract][Full Text] [Related]
18. Enoxaparin Thromboprophylaxis Dosing and Anti-Factor Xa Levels in Low-Weight Patients.
Yam L; Bahjri K; Geslani V; Cotton A; Hong L
Pharmacotherapy; 2019 Jul; 39(7):749-755. PubMed ID: 31112313
[TBL] [Abstract][Full Text] [Related]
19. Fixed-dose enoxaparin after bariatric surgery: the influence of body weight on peak anti-Xa levels.
Celik F; Huitema AD; Hooijberg JH; van de Laar AW; Brandjes DP; Gerdes VE
Obes Surg; 2015 Apr; 25(4):628-34. PubMed ID: 25223871
[TBL] [Abstract][Full Text] [Related]
20. Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis.
Fox NS; Laughon SK; Bender SD; Saltzman DH; Rebarber A
Obstet Gynecol; 2008 Oct; 112(4):884-9. PubMed ID: 18827132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
